By Lynn Yap | Board Advisor, Life Sciences Week 2025
In health innovation, speed matters. The faster we can move a validated idea into the hands of clinicians and patients, the faster we can improve outcomes. But there’s a common misconception about how to achieve that speed.
It’s not always about raising more capital, hiring faster, or building more features.
Often, the real accelerator is who you build with.
Partnerships, when done well, can turn a promising idea into a widely adopted solution — not just by opening doors, but by removing barriers you might never see on your own.
Why ecosystems beat go-it-alone growth
The health innovation landscape is complex by design. No single company, however well-funded, can navigate regulatory pathways, evidence generation, reimbursement, adoption, and scale-up entirely on its own.
An ecosystem approach recognises this reality and leverages the strengths of multiple players:
• Industry partners bring resources, distribution, and credibility.
• Academic institutions contribute research expertise and access to diverse patient populations.
• Health systems provide the operational context and early adoption pathways.
• Investors offer not just capital but market intelligence and commercial discipline.
When these stakeholders collaborate intentionally, the result is a faster, more resilient route to market — and often, a better product.
From transactional to transformational partnerships
Not all partnerships are created equal. Many are transactional: a single pilot, a short-term licensing agreement, a joint press release. They can serve a purpose, but they rarely create lasting growth.
Transformational partnerships, on the other hand, share three traits:
1. Aligned incentives – All parties gain from the same outcomes, whether it’s improved patient care, cost savings, or market expansion.
2. Integrated workstreams – Collaboration happens deep in the operational layers, not just at the executive level.
3. Shared risk and reward – Partners commit resources — time, expertise, funding — with an understanding that success is mutual.
Case study: Scaling precision oncology through partnership
SOPHiA GENETICS, headquartered in Rolle near Geneva, offers a clear example of how the right ecosystem can accelerate impact. The company partnered with Memorial Sloan Kettering Cancer Center (MSK) in the US and BioReference Laboratories to make MSK-ACCESS, a leading liquid biopsy assay, available globally through the SOPHiA DDM platform.
This wasn’t just about adding a new test to a menu. By combining MSK’s clinical expertise, SOPHiA’s AI-driven analytics, and BioReference’s broad distribution network, the partnership created an end-to-end solution — from test processing to data interpretation — that could be scaled rapidly across multiple markets.
The collaboration didn’t only expand reach; it also strengthened the quality of clinical insights, enhanced regulatory positioning, and accelerated adoption by offering healthcare providers a ready-to-deploy solution they could trust.
Three principles for ecosystem-led growth
From observing partnerships across industries — and from my work with technology platforms and innovation collaborations — I’ve seen three principles consistently lead to stronger outcomes:
1. Build around a shared problem, not just a shared market
The most durable partnerships focus on solving a problem that matters to all parties, not just on selling into the same customer base.
2. Start small, scale fast
Begin with a defined project or pilot but design it so it can expand quickly if it works. This builds trust without requiring massive upfront commitments.
3. Invest in relationship infrastructure
Regular joint reviews, shared KPIs, and clear decision-making processes prevent partnerships from stalling when leadership or market conditions change.
Why this matters for Life Sciences Week
Life Sciences Week brings together precisely the mix of stakeholders needed for ecosystem-led growth: entrepreneurs, investors, academics, and health system leaders. It’s a rare opportunity to see not only where the innovation is happening, but also where the bridges could be built.
Whether you’re a start-up looking for your first hospital partner, a corporate exploring co-development, or an investor aiming to de-risk your portfolio, the most impactful conversations will likely happen at the intersections.
The competitive advantage of thinking like an ecosystem
When partnerships are at the centre of your growth strategy:
• Adoption is faster because your solution arrives through trusted channels.
• Evidence builds quicker through pooled resources and shared data.
• Market access expands without the need to build every pathway yourself.
In health innovation, no one wins alone. The companies that scale — and stay scaled — are those that see themselves not as isolated players, but as part of a network working toward a shared vision of better health.
Life Sciences Week is a reminder that our biggest leaps forward often happen when we stop thinking in silos and start thinking in ecosystems. The question isn’t whether partnerships can accelerate your growth — it’s whether you can afford to grow without them.
***
About the Author
Lynn Yap is a Board Advisor to Life Sciences Week 2025 and the author of The Altruistic Capitalist. She advises startups, corporates, and founders on commercial strategy, ethical innovation, and long-term value creation.
Connect on LinkedIn and Email| Explore more at AltruisticCapitalist.com
